CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities
Acquiring Company
CoreRx
Acquired Company
Societal CDMO
ClearwaterGainesvilleManufacturingBiotechnologyHealthcarePharmaceuticalManufacturingBiotechnologyDescription
CoreRx, Inc. has successfully completed the acquisition of Societal CDMO, Inc., a contract development and manufacturing organization. This acquisition will enhance CoreRx's capabilities in drug formulation and GMP manufacturing, strengthening its position as an industry-leading CDMO.
Quick answer
CoreRx is acquiring Societal CDMO, announced April 8, 2024. CoreRx is based in Clearwater, Florida, United States.
- How much did CoreRx pay for Societal CDMO?
- The deal value was not disclosed.
- What does CoreRx do?
- CoreRx, Inc. is an industry leading CDMO, providing innovative drug formulation, development, and GMP manufacturing to global pharmaceutical and biotech partners.
- Where are CoreRx and Societal CDMO based?
- CoreRx is based in Clearwater, Florida, United States. Societal CDMO is based in Gainesville, Florida, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- ProMed Pharma LLC acquires SpineThera's Manufacturing Capabilities and an Option to License Intellectual Property (April 3, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- IMCD Spain acquires Cobapharma, S.L.U to strengthen its Pharmaceuticals presence (April 24, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
Who to call at CoreRx, and when
When CoreRx changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CoreRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CoreRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CoreRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CoreRx makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Societal CDMO?
Societal CDMO was acquired by CoreRx, based in Clearwater. The deal was reported on April 8, 2024. CoreRx, Inc. is an industry leading CDMO, providing innovative drug formulation, development, and GMP manufacturing to global pharmaceutical and biotech partners. CoreRx is privately held and operates in Manufacturing.
When did CoreRx acquire Societal CDMO?
CoreRx's acquisition of Societal CDMO was reported on April 8, 2024. CoreRx, Inc. has successfully completed the acquisition of Societal CDMO, Inc., a contract development and manufacturing organization. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Societal CDMO do?
Societal CDMO, Inc. is a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics. It is privately held, operating in Manufacturing, and is based in Gainesville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.